From Evestra Signs Deal with Glemark for Generic Version of NuvaRing:

Circular—

Stock image from Unsplash user Julian Bock. Used in accordance with Unsplash creative commons license https://unsplash.com/license https://unsplash.com/search/circular-ring?photo=Y6-GL40aPPs

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
COVID-19 Special Report: Sustaining Clinical Research During the Crisis
Leveraging technology & expertise to ensure a continual journey from trials to treatments
PRA Health Sciences

From Our Editors · Special Report
Xcelerating Life Sciences San Diego: Special Report
Learn what's fueling San Diego's biotech investment and partnership opportunities

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination Period

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Biogen Alzheimer’s Drug in FDA's Court Following Completion of Filing

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

Kaleido Bio CEO Lawton Resigns; Company Plans Search for Successor

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

From Evestra Signs Deal with Glemark for Generic Version of NuvaRing:

Underwriters and Partners

COVID-19 Special Report: Sustaining Clinical Research During the Crisis

Xcelerating Life Sciences San Diego: Special Report

The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development

Xconomy on Demand

We offer a number of ways to subscribe for free!